Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.24.3
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, shares in Millions
3 Months Ended 9 Months Ended
Sep. 20, 2024
Aug. 19, 2024
Aug. 14, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Offering price (in usd per share)     $ 21.75          
Share-based compensation expense       $ 11,800,000 $ 14,900,000 $ 30,500,000 $ 37,000,000.0  
Accrued expenses and other current liabilities       196,290,000   196,290,000   $ 185,305,000
Equity Plan 2021                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Accrued expenses and other current liabilities               $ 18,100,000
Equity Classified Awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based compensation expense       9,300,000 8,900,000 27,200,000 22,800,000  
Liability Classified Awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based compensation expense       $ 2,500,000 $ 6,000,000.0 $ 3,300,000 $ 14,200,000  
Restricted Stock Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted (in shares)           1.8    
Restricted Stock Units Time Vested                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted (in shares)           1.3    
Restricted Stock Units Performance Vesting                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted (in shares)           0.5    
Performance Stock Units (PSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted (in shares)           0.5    
Vesting period           3 years    
Performance Shares, Adjusted EBITDA                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted (in shares)           0.3    
Vesting period           3 years    
Performance Shares, Adjusted EBITDA | Tranche 1                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of awards           33.33%    
Performance Shares, Adjusted EBITDA | Tranche 2                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of awards           33.33%    
Performance Shares, Adjusted EBITDA | Tranche 3                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of awards           33.33%    
Performance Shares, Leverage Ratio                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards granted (in shares)           0.2    
Performance Shares, Leverage Ratio | Tranche 1                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of shares to vest           33.33%    
Performance Shares, Leverage Ratio | Tranche 2                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of shares to vest           33.33%    
Performance Shares, Leverage Ratio | Tranche 3                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of shares to vest           33.33%    
Term Loan Facility                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Repayments of debt $ 200,000,000 $ 110,000,000.0            
Primary Shares                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Sale of common stock (in shares)     6.0          
Proceeds from issuance of common stock     $ 130,500,000          
Underwriting discounts and other offering expenses     6,100,000          
Sale of stock, net proceeds     $ 124,400,000          
Secondary Shares                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Sale of common stock (in shares)     7.8          
Sale of stock, net proceeds     $ 0